尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Moxie Dwight, Vice-Président Senior, Avocat Général et Secrétaire. Insider active across 1 company, notably Revance Therapeutics, Inc.. Aggregated, 13 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €737k. History available since 27 September 2021. The latest transaction was filed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Moxie Dwight is Senior Vice President, General Counsel and Secretary at Revance Therapeutics, Inc. (XNAS). The declarant has 13 filings in total, and across the 13 recent sampled filings between 2021-09-28 and 2025-02-06, sales total EUR 737387 and the most frequent transaction nature is Attribution.